N-Acetylglucosamine

N-Acetylglucosamine

Haworth projection
Names
IUPAC name β-D-(Acetylamino)-2-deoxy-glucopyranose
Other names N-Acetyl-D-glucosamine GlcNAc NAG
Identifiers
CAS Number	7512-17-6 Y
3D model (JSmol)	Interactive image
Beilstein Reference	1247660
ChEBI	CHEBI:28009 N
ChEMBL	ChEMBL447878 Y
ChemSpider	22563 Y
ECHA InfoCard	100.028.517
EC Number	231-368-2
Gmelin Reference	721281
KEGG	C03878
PubChem CID	24139
UNII	V956696549 N
CompTox Dashboard (EPA)	DTXSID301045979 DTXSID3045855, DTXSID301045979
InChI InChI=1S/C8H15NO6/c1-3(11)9-5-7(13)6(12)4(2-10)15-8(5)14/h4-8,10,12-14H,2H2,1H3,(H,9,11)/t4-,5-,6-,7-,8-/m1/s1 Y Key: OVRNDRQMDRJTHS-FMDGEEDCSA-N Y InChI=1/C8H15NO6/c1-3(11)9-5-7(13)6(12)4(2-10)15-8(5)14/h4-8,10,12-14H,2H2,1H3,(H,9,11)/t4-,5-,6-,7-,8-/m1/s1 Key: OVRNDRQMDRJTHS-FMDGEEDCBL
SMILES O=C(N[C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@H]1O)CO)C
Properties
Chemical formula	C8H15NO6
Molar mass	221.21
Melting point	211
Related compounds
Related Monosaccharides	N-Acetylgalactosamine
Related compounds	Glucosamine Glucose
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). N verify (what is YN ?) Infobox references

N-Acetylglucosamine (GlcNAc) is an amide derivative of the monosaccharide glucose. It is a secondary amide between glucosamine and acetic acid. It is significant in several biological systems.

It is part of a biopolymer in the bacterial cell wall, which is built from alternating units of GlcNAc and N-acetylmuramic acid (MurNAc), cross-linked with oligopeptides at the lactic acid residue of MurNAc. This layered structure is called peptidoglycan (formerly called murein).

GlcNAc is the monomeric unit of the polymer chitin, which forms the exoskeletons of arthropods like insects and crustaceans. It is the main component of the radulas of mollusks, the beaks of cephalopods, and a major component of the cell walls of most fungi.

Polymerized with glucuronic acid, it forms hyaluronan.

GlcNAc has been reported to be an inhibitor of elastase release from human polymorphonuclear leukocytes (range 8–17% inhibition), however this is much weaker than the inhibition seen with N-acetylgalactosamine (range 92–100%).^[1]

It has been proposed as a treatment for autoimmune diseases and recent tests have claimed some success.^[2][3]

O-GlcNAcylation is the process of adding a single N-acetylglucosamine sugar to the serine or threonine of a protein.^[4] Comparable to phosphorylation, addition or removal of N-acetylglucosamine is a means of activating or deactivating enzymes or transcription factors.^[4] In fact, O-GlcNAcylation and phosphorylation often compete for the same serine/threonine sites.^[4] O-GlcNAcylation most often occurs on chromatin proteins, and is often seen as a response to stress.^[4]

Hyperglycemia increases O-GlcNAcylation, leading to insulin resistance.^[5] Increased O-GlcNAcylation due to hyperglycemia is evidently a dysfunctional form of O-GlcNAcylation. O-GlcNAcylation decline in the brain with age is associated with cognitive decline. When O-GlcNAcylation was increased in the hippocampus of aged mice, spatial learning and memory improved.^[6]

• Keratan sulfate
• N-Acetylgalactosamine (GalNAc)
• N-Acetyllactosamine synthase
• Wheat germ agglutinin, a plant lectin that binds to this substrate

• Re Multiple Sclerosis